T he idiopathic long QT syndrome (LQTS) is a congenital disease with frequent familial transmission, characterized primarily by prolongation of the QT interval and by the occurrence of life-threatening tachyarrhythmias, particularly in association with emotional or physical stress.1-5 Among untreated symptomatic patients, lethality is high, with 20% mortality in the first year after the initial syncope and approximately 50% within 10 years3; however, the risk of death varies among different families. This poor prognosis has been significantly improved by the use of pharmacological or surgical antiadrenergic therapy or both, which has reduced long-term mortality to <5%.3,4,6 The availability of effective therapy for this often lethal disease emphasizes the importance of early and accurate diagnosis. Unfortunately, there is frequently a delay in the diagnosis of LQTS, and patients with syncope are often misdiagnosed, most commonly as affected by a seizure disorder.
In its most characteristic presentation, with obvious QT prolongation and stress-induced syncope, the diagnosis of LQTS is quite straightforward for physicians aware of the disease. In cases of borderline QT prolongation and/or absence of symptoms, however, a correct diagnosis may be more difficult. It was for this reason that a first set of diagnostic criteria (Table 1) The second event has been the progressive realization that the spectrum of clinical abnormalities observed in LQTS is larger than previously realized and that it includes several features that might contribute to a more accurate diagnosis. These abnormalities have been documented, almost always in case-control studies, to occur frequently in LQTS patients and quite rarely among healthy control subjects. They include the following: (1) a larger than normal area of negative potentials in the anterior chest leads and a complex multipolar distribution as assessed by body surface mapping.9-11 These findings suggest the presence of delayed repolarization of the anterior ventricular wall, of regional electrical disparities in the recovery process, and of a high degree of dispersion of ventricular recovery times. (2) It was on the basis of these developments and of the attendant implications that we felt it necessary to upgrade the criteria for diagnosing LQTS. The new diagnostic criteria are listed in Table 2 , with relative points assigned to various ECG, clinical, and familial findings. The score ranges from a minimum value of 0 to a maximum value of 9 points. On the basis of our experience, we have arbitrarily divided the point score into three probability categories: (1) c1 point, low probability of LQTS; (2) 2 or 3 points, intermediate probability of LQTS; and (3) >4 points, high probability of LQTS. Since QT, overcorrects at fast heart rates, additional diagnostic caution is necessary when scaling with a tachycardiac patient.
Note, QT. >480 msec1/2 is assigned the highest value (3 points), but QT. prolongation (QTC >450 msec112) per se is not an absolute prerequisite for the diagnosis of LQTS. Note also that torsade de pointes and syncope with stress are each assigned a value of 2 points, but they are mutually exclusive. Torsade de pointes receives no points if the patient is taking drugs known to favor QT prolongation. We felt it important to include some aspect of family history in the diagnostic criteria, but we assigned low point values for the presence of family members with overt manifestations of the disease to avoid a potentially excessive hereditary bias. The diagnostic weight of "lower-than-normal" heart rate also has now been reduced and is restricted to children24; we suggest using the lower second percentile from the large study by Davignon et 
